Vifor Pharma reports positive outcome of the phase-IIIb DIAMOND trial of Veltassa®
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma today announced positive findings in the completed phase-IIIb DIAMOND trial of Veltassa® in heart failure patients with either ma......